SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

The fundamentals of cardiovascular calcification: from cells to therapy

This project aims to uncover mechanisms of cardiovascular calcification using zebrafish to identify new therapeutic targets for improved treatment options.

Subsidie
€ 1.209.375
2022

Projectdetails

Introduction

With this project, I propose to identify fundamental mechanisms of cardiovascular calcification (CVC) and new therapeutic targets using zebrafish as a model system. CVC, characterized by progressive calcification of the soft tissue causing impaired blood circulation, is a frequent form of cardiovascular disease.

Background

Because the pathophysiology of CVC is highly heterogeneous, the exact cell types and signaling pathways triggering tissue calcification are still unknown, thus limiting therapy options. Most studies on CVC rely on in vitro systems, which fail to reproduce the multicellular environment, or mammalian in vivo models, which are limited for live imaging and high-throughput analyses.

Research Proposal

By combining my expertise in cardiovascular research and bone biology, I propose to use zebrafish as a model to elucidate the multifactorial mechanisms of CVC, focusing on different developmental stages and cardiovascular tissues.

Aim 1

  1. I will use a broad array of zebrafish genetic models to characterize the cellular dynamics, molecular mechanisms, and functional impact of CVC in vivo.
  2. I will also study the role of specific cell populations present in regenerating valves and human valve implants with CVC.

Aim 2

  1. I propose to identify new local and systemic therapeutic strategies to block/reverse CVC, taking advantage of the zebrafish's amenability for genetic manipulation and high-throughput screening.
  2. I will recruit bone-degrading cells to the CVC site and determine their potential to reverse tissue calcification.
  3. Moreover, I will select a short list of small molecules identified in a large-scale screen in zebrafish and will test their therapeutic potential in cardiovascular cells derived from hiPSCs of CVC patients.

Conclusion

Altogether, with this interdisciplinary approach, I expect to bring a new perspective on the mechanisms and therapeutic targets to block/reverse CVC, which could have a considerable impact on the European population, severely affected by these diseases.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.209.375
Totale projectbegroting€ 1.209.375

Tijdlijn

Startdatum1-10-2022
Einddatum30-9-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEpenvoerder

Land(en)

France

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Real-time Multiscale Imaging of Pathological Calcification - Zooming in on Aortic Valve Calcification

Developing a designer tissue imaging platform to dynamically study extracellular matrix changes in Calcifying Aortic Valve Disease, aiming to uncover mechanisms for future drug therapies.

ERC Advanced...€ 2.500.000
2025
Details

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

ERC Advanced...€ 2.500.000
2023
Details

Decoding Extracellular Vesicle-mediated organ crosstalk in vivo

This project aims to investigate hepatic extracellular vesicle-mediated inter-organ communication in vivo using a transparent zebrafish model to enhance understanding of their role in health and disease.

ERC Starting...€ 1.500.000
2023
Details

Development of novel 3D vascularized cardiac models to investigate Coronary Microvascular Disease

The 3DVasCMD project aims to develop a 3D vascularized cardiac model using iPSC technology to study coronary microvascular disease and identify therapeutic targets for improved cardiovascular health.

ERC Starting...€ 1.496.395
2022
Details

Mechanisms and consequences of cell state transitions during heart regeneration

This project aims to uncover the coordinated cellular responses in zebrafish heart regeneration post-injury using single-cell genomics and computational methods to enhance understanding of organ repair mechanisms.

ERC Consolid...€ 2.000.000
2023
Details
ERC Advanced...

Real-time Multiscale Imaging of Pathological Calcification - Zooming in on Aortic Valve Calcification

Developing a designer tissue imaging platform to dynamically study extracellular matrix changes in Calcifying Aortic Valve Disease, aiming to uncover mechanisms for future drug therapies.

ERC Advanced Grant
€ 2.500.000
2025
Details
ERC Advanced...

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

ERC Advanced Grant
€ 2.500.000
2023
Details
ERC Starting...

Decoding Extracellular Vesicle-mediated organ crosstalk in vivo

This project aims to investigate hepatic extracellular vesicle-mediated inter-organ communication in vivo using a transparent zebrafish model to enhance understanding of their role in health and disease.

ERC Starting Grant
€ 1.500.000
2023
Details
ERC Starting...

Development of novel 3D vascularized cardiac models to investigate Coronary Microvascular Disease

The 3DVasCMD project aims to develop a 3D vascularized cardiac model using iPSC technology to study coronary microvascular disease and identify therapeutic targets for improved cardiovascular health.

ERC Starting Grant
€ 1.496.395
2022
Details
ERC Consolid...

Mechanisms and consequences of cell state transitions during heart regeneration

This project aims to uncover the coordinated cellular responses in zebrafish heart regeneration post-injury using single-cell genomics and computational methods to enhance understanding of organ repair mechanisms.

ERC Consolidator Grant
€ 2.000.000
2023
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

EIC Pathfinder€ 4.475.946
2022
Details

Bringing 3D cardiac tissues to high throughput for drug discovery screens

Developing a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability.

EIC Transition€ 1.457.500
2023
Details

Comprehensive Analysis of RBM20-induced Dilated Cardiomyopathies using Omics Approaches and Repair Interventions

CARDIOREPAIR aims to identify and therapeutically target RBM20 mutations in dilated cardiomyopathy using high-throughput genomics and bioengineering to improve heart health outcomes.

EIC Pathfinder€ 4.349.410
2023
Details
EIC Pathfinder

Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

EIC Pathfinder
€ 4.475.946
2022
Details
EIC Transition

Bringing 3D cardiac tissues to high throughput for drug discovery screens

Developing a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability.

EIC Transition
€ 1.457.500
2023
Details
EIC Pathfinder

Comprehensive Analysis of RBM20-induced Dilated Cardiomyopathies using Omics Approaches and Repair Interventions

CARDIOREPAIR aims to identify and therapeutically target RBM20 mutations in dilated cardiomyopathy using high-throughput genomics and bioengineering to improve heart health outcomes.

EIC Pathfinder
€ 4.349.410
2023
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.